Study Identifies Role of C-reactive Protein in Diabetic Kidney Inflammation

A research team from the School of Chinese Medicine at the University of Hong Kong’s LKS Faculty of Medicine has identified a mechanism by which C-reactive protein (CRP) contributes to kidney inflammation in diabetic patients. The study found that CRP exacerbates diabetic kidney disease (DKD) through a pathway involving the Smad3-NLRP3 inflammasome. This discovery highlights potential targets for future therapeutic approaches to address DKD.

The findings suggest that CRP, a protein commonly associated with inflammation, plays a direct role in worsening kidney damage linked to diabetes. Researchers determined that the Smad3-NLRP3 inflammasome-dependent mechanism is central to this process, providing insight into how inflammation progresses in diabetic kidneys. The study proposes that further exploration into therapies targeting either CRP or the Smad3-NLRP3 pathway could pave the way for new treatments aimed at mitigating DKD-related complications.

Date: 13 March, 2025

Newsflash | Powered by GeneOnline AI

Author

Mark Chiang

Related Post

Oncology Insights

ASCO 2026 Preview: The Rising Role of Metabolic Drugs in Cancer Survivorship

2026-05-28

go prime

Confronting the Rising Cardiometabolic Epidemic in Greater China Through Precision Health and Policy Reforms

2026-03-09

In-Depth

Climate Extremes Heighten Diabetes Incidence, Hospitalizations and Mortality: Global Evidence and Implications

2025-11-13